MedPath

Study to investigate the sensitivity and specificity of 3.0 Tesla MRI, MRS and ultrasound imaging for carotid artery plaque dimension and composition assessment.

Conditions
atherosclerosis
n/a
10003216
Registration Number
NL-OMON36476
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

carotid artery stenosis, > 70 %, scheduled for carotid endarterectomy

Exclusion Criteria

Not suitable for MRI (e.g. metal in the body, e.g. as a result of pacemaker or artificial cardiac valve implant), claustrophobia, former surgical procedures in the carotid area

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Imaging<br /><br><br /><br>1. Total plaque volume, plaque calcification volume, plaque haemorrhage<br /><br>volume, lipid rich necrotic core volume, fibrous cap thickness, as assessed by<br /><br>3.0 Tesla MRI.<br /><br>2. The ratio of the integrated lipid peak versus the unsuppressed water peak<br /><br>(expressed as a percentage), as assessed by MRS.<br /><br>3. Carotid plaque presence and location, maximum plaque thickness and plaque<br /><br>composition, as assessed by B-mode ultrasound imaging.<br /><br>4. Carotid intima-media thickness, arterial stiffness, blood flow velocity<br /><br>measured by ultrasound imaging.<br /><br><br /><br>Histology<br /><br><br /><br>5. Plaque size, morphology and phenotype (presence of collagen, smooth muscle<br /><br>cells, calcifications, macrophages, thrombus and fat), as assessed by histology<br /><br>analysis.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>no secundary study parameters</p><br>
© Copyright 2025. All Rights Reserved by MedPath